BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30359892)

  • 21. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
    Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
    PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment.
    Krell-Roesch J; Pink A; Roberts RO; Stokin GB; Mielke MM; Spangehl KA; Bartley MM; Knopman DS; Christianson TJ; Petersen RC; Geda YE
    J Am Geriatr Soc; 2016 Dec; 64(12):2479-2486. PubMed ID: 27801933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment.
    Fleisher A; Grundman M; Jack CR; Petersen RC; Taylor C; Kim HT; Schiller DH; Bagwell V; Sencakova D; Weiner MF; DeCarli C; DeKosky ST; van Dyck CH; Thal LJ;
    Arch Neurol; 2005 Jun; 62(6):953-7. PubMed ID: 15956166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
    Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of depression in predicting time to conversion to mild cognitive impairment.
    Dean K; Oulhaj A; Zamboni G; deJager CA; Wilcock GK
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):727-34. PubMed ID: 23611364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype.
    Carroll JE; Small BJ; Tometich DB; Zhai W; Zhou X; Luta G; Ahles TA; Saykin AJ; Nudelman KNH; Clapp JD; Jim HS; Jacobsen PB; Hurria A; Graham D; McDonald BC; Denduluri N; Extermann M; Isaacs C; Dilawari AA; Root J; Stern RA; Mandelblatt JS;
    Cancer; 2019 Dec; 125(24):4516-4524. PubMed ID: 31553501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.
    Wierenga CE; Dev SI; Shin DD; Clark LR; Bangen KJ; Jak AJ; Rissman RA; Liu TT; Salmon DP; Bondi MW
    J Cereb Blood Flow Metab; 2012 Aug; 32(8):1589-99. PubMed ID: 22549621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    Kim H; Levine A; Cohen D; Gehrman P; Zhu X; Devanand DP; Lee S; Goldberg TE;
    J Alzheimers Dis; 2022; 87(4):1567-1580. PubMed ID: 35491776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative health deficits,
    Ward DD; Wallace LMK; Rockwood K
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):136-142. PubMed ID: 33188132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E polymorphism ε4-stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: A prospective cohort study.
    Duan H; Sun Y; Liu Q; Fu J; Huang L; Wang Z; Zhao J; Li Z; Li W; Liu H; Ma F; Chen Y; Sun C; Wang G; Du Y; Huang G
    Eur J Neurol; 2022 May; 29(5):1385-1393. PubMed ID: 35104029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.
    Shi J; Leporé N; Gutman BA; Thompson PM; Baxter LC; Caselli RJ; Wang Y;
    Hum Brain Mapp; 2014 Aug; 35(8):3903-18. PubMed ID: 24453132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Taub ES
    Neuropsychology; 2011 Nov; 25(6):679-89. PubMed ID: 21728427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
    Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
    Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
    Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.